GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma

NCT00495846 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: Octreotide-LAR, Lanreotide Autogel
OTHER: Locoregional treatments

Sponsor

Federico II University

Collaborators

[object Object]